{"entity":{"id":"abl2","kind":"target","name":"ABL2","aka":["ABL proto-oncogene 2, non-receptor tyrosine kinase","Tyrosine-protein kinase ABL2"],"tldr":"ABL2 (Tyrosine-protein kinase ABL2) is a protein kinase, an enzyme that switches other proteins on by adding phosphate groups. The public catalogues list it as a drug target, an oncogene driver and a biomarker, and clinical evidence ties its variants to diagnosis, prognosis or drug response. Tied to Breast cancer, Endometrial cancer, Lung cancer and 2 more.","summary":"Non-receptor tyrosine-protein kinase that plays an ABL1-overlapping role in key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion and receptor endocytosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like MYH10 (involved in movement); CTTN (involved in signalling); or TUBA1 and TUBB (microtubule subunits). Binds directly F-actin and regulates actin cytoskeletal structure through its F-actin-bundling activity.\n\nCIViC holds 1 clinical evidence item and 0 assertions across 3 variants, naming Imatinib and Dasatinib. Open Targets scores its association with cancer at 0.68 (direct and indirect evidence; datatypes literature 0.89, animal model 0.26, genetic association 0.33, somatic mutation 0.83). IntOGen calls it a driver in 2 cohorts (2 activating, 0 loss-of-function), covering Invasive Breast Carcinoma, Endometrial Carcinoma.","asOf":"2026-09-23","links":[{"label":"HGNC HGNC:77","url":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:77"},{"label":"UniProt P42684","url":"https://www.uniprot.org/uniprotkb/P42684/entry"},{"label":"NCBI Gene 27","url":"https://www.ncbi.nlm.nih.gov/gene/27"},{"label":"Ensembl ENSG00000143322","url":"https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000143322"}],"tags":["cancer-genes-wave"],"related":["civic","open-targets","intogen"],"cancers":["breast-cancer","endometrial","lung-cancer","skin-cancer","nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Written by scripts/fetch-cancer-genes.ts from CIViC, Open Targets, IntOGen, HGNC and UniProt; the function text is UniProt's, condensed and in UK spelling. Roles: CIViC lists 2 therapies; IntOGen calls it an activating (Act) driver in 2 cohorts; CIViC holds 1 clinical evidence items on its variants. Evidence tier \"clinical-evidence\" is the strongest of those signals.","Prevalence not recorded: none of the sources gives a positivity rate."],"provenance":{"editedBy":"scripts/fetch-cancer-genes.ts (CIViC, Open Targets, IntOGen, HGNC, UniProt)","editedOn":"2026-09-23"},"symbol":"ABL2","role":["drug-target","oncogene-driver","biomarker"],"evidenceTier":"clinical-evidence","sources":[{"label":"HGNC HGNC:77","url":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:77","note":"approved symbol, name, aliases, locus and cross-references (hgnc_complete_set.txt)"},{"label":"UniProt P42684","url":"https://www.uniprot.org/uniprotkb/P42684/entry","note":"protein name, function text, keywords and locations (REST API)"},{"label":"CIViC gene ABL2","url":"https://civicdb.org/features/101","note":"1 evidence items, 0 assertions, 3 variants; diseases: Lung Adenocarcinoma (GraphQL API, CC0)"},{"label":"Open Targets ENSG00000143322","url":"https://platform.opentargets.org/target/ENSG00000143322/associations","note":"association with cancer (MONDO_0004992) 0.68; per-cancer scores at or above 0.5: skin cancer 0.52, breast cancer 0.57, lung cancer 0.53 (GraphQL API, CC0)"},{"label":"IntOGen ABL2","url":"https://www.intogen.org/search?gene=ABL2","note":"driver in 2 cohorts (Act 2, LoF 0); Compendium_Cancer_Genes.tsv release 20240920, CC0 1.0"}],"hgnc":"HGNC:77","ensembl":"ENSG00000143322","uniprot":"P42684","entrez":"27","biology":"Non-receptor tyrosine-protein kinase that plays an ABL1-overlapping role in key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion and receptor endocytosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like MYH10 (involved in movement); CTTN (involved in signalling); or TUBA1 and TUBB (microtubule subunits). Binds directly F-actin and regulates actin cytoskeletal structure through its F-actin-bundling activity. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as CRK, CRKL, DOK1 or ARHGAP35. Adhesion-dependent phosphorylation of ARHGAP35 promotes its association with RASA1, resulting in recruitment of ARHGAP35 to the cell periphery where it inhibits RHO. Phosphorylates multiple receptor tyrosine kinases like PDGFRB and other substrates which are involved in endocytosis regulation such as RIN1. Location: Cytoplasm, cytoskeleton (UniProt). Locus 1q25.2 (HGNC).","whereFound":["Breast cancer: Open Targets association 0.57 with breast cancer (MONDO_0007254); IntOGen driver in 1 cohort (BRCA)","Endometrial cancer: IntOGen driver in 1 cohort (UCEC)","Lung cancer: Open Targets association 0.53 with lung cancer (MONDO_0008903)","Skin cancer: Open Targets association 0.52 with skin cancer (MONDO_0002898)","Non-small-cell lung cancer: CIViC evidence names this disease"],"targetClass":"kinase","prevalence":[]},"route":"/targets/abl2/","neighbours":{"collection":[{"id":"civic","kind":"collection","name":"CIViC","route":"/collections/civic/"},{"id":"intogen","kind":"collection","name":"IntOGen","route":"/collections/intogen/"},{"id":"open-targets","kind":"collection","name":"Open Targets Platform","route":"/collections/open-targets/"}],"cancer":[{"id":"breast-cancer","kind":"cancer","name":"Breast cancer (all types)","route":"/cancers/breast-cancer/"},{"id":"endometrial","kind":"cancer","name":"Endometrial cancer","route":"/cancers/endometrial/"},{"id":"lung-cancer","kind":"cancer","name":"Lung cancer (all types)","route":"/cancers/lung-cancer/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"},{"id":"skin-cancer","kind":"cancer","name":"Skin cancer (all types)","route":"/cancers/skin-cancer/"}]}}